A drug developed for type 2 diabetes has “significantly reversed memory loss” in mice with Alzheimer’s disease, and researchers now want to test it on humans.
The treatment is exciting for scientists because it works by protecting the brain cells attacked by Alzheimer’s disease in three separate ways, rather than relying on a single approach.
And seeing as the drug has already been tested and approved for use in humans, it’s something that could hit the market a lot faster than other experimental treatment options. Read more.
Written by: Fiona MacDonald
Share this story
‹ More Featured Studies